DanCann Pharma A/S with Inspection by Danish Medicines Agency in Q4 2022: Expects to Obtain EU-GMP Approval by End of 2022 | MarketScreener
Copenhagen, Denmark, November 8, 2022 – DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”), a Danish cannabinoid-powered company, hereby announces that the Company plans to obtain EU-GMP approval of the Biotech Pharm1 production facilities (” BP1″) in the fourth quarter of 2022. Earlier this year Dan Cann Pharma has applied for approval of …